- Measurement of the integrated luminosity of the Phase 2 data of the Belle II experiment2020 | Matematicko-fyzikální fakulta
- DUET: A Phase 2 Study Evaluating the Efficacy and Safety of Sparsentan in Patients with FSGS2018 | 1. lékařská fakulta
- A phase 2 study of venetoclax plus R-CHOP as first-line treatment for patients with diffuse large B-cell lymphoma2021 | 1. lékařská fakulta
- Parsaclisib, a PI3Kδ inhibitor, in relapsed and refractory follicular lymphoma (CITADEL-203): a phase 2 study2023 | 1. lékařská fakulta, Lékařská fakulta v Hradci Králové
- Treosulfan vs busulfan conditioning for allogeneic bmt in children with nonmalignant disease: a randomized phase 2 trial2024 | 2. lékařská fakulta
- Safety and efficacy of ofatumumab in relapsing-remitting multiple sclerosis A phase 2 study2014 | 1. lékařská fakulta
- A phase 2 study of isatuximab monotherapy in patients with multiple myeloma who are refractory to daratumumab2021 | 1. lékařská fakulta
- A phase 2 study of ibrutinib in combination with bortezomib and dexamethasone in patients with relapsed/refractory multiple myeloma2020 | 1. lékařská fakulta
- Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial2015 | 1. lékařská fakulta
- Long-term Safety and Efficacy of the Anti-MAdCAM-1 Monoclonal Antibody Ontamalimab [SHP647] for the Treatment of Ulcerative Colitis: The Open-label Study TURANDOT II2021 | Lékařská fakulta v Hradci Králové
- Parsaclisib, a PI3Kδ inhibitor, in relapsed and refractory mantle cell lymphoma (CITADEL-205): a phase 2 study2023 | 1. lékařská fakulta
- Klinická studie fáze 2 s DNA vakcínou kódující myelinový bazický protein u roztroušené sklerózy2008 | 1. lékařská fakulta
- Nivolumab for relapsed/refractory classical Hodgkin lymphoma: 5-year survival from the pivotal phase 2 CheckMate 205 study2023 | 1. lékařská fakulta
- Oral ponesimod in patients with chronic plaque psoriasis: a randomised, double-blind, placebo-controlled phase 2 trial2014 | 3. lékařská fakulta
- ADAMANT: a placebo-controlled randomized phase 2 study of AADvac1, an active immunotherapy against pathological tau in Alzheimer's disease2021 | 2. lékařská fakulta
- A phase 2, multicenter study investigating ofatumumab and bendamustine combination in patients with untreated or relapsed CLL2016 | Lékařská fakulta v Hradci Králové
- Efficacy and Safety of Sarilumab for the Treatment of Posterior Segment Noninfectious Uveitis (SARIL-NIU): The Phase 2 SATURN Study2019 | 1. lékařská fakulta
- Anti-MAdCAM antibody (PF-00547659) for ulcerative colitis (TURANDOT): a phase 2, randomised, double-blind, placebo-controlled trial2017 | Lékařská fakulta v Hradci Králové
- Enzalutamide monotherapy in hormone-naive prostate cancer: primary analysis of an open-label, single-arm, phase 2 study2014 | 1. lékařská fakulta, 3. lékařská fakulta
- Vinorelbine plus trastuzumab combination as first-line therapy for HER 2-positive metastatic breast cancer patients: an international phase 2 trial2006 | 1. lékařská fakulta
- Vinorelbine plus trastuzumab combination as first-line therapy for HER 2-positive metastatic breast cancer patients: an international phase 2 trial2006 | Fakulta tělesné výchovy a sportu
- Phase 2 study of PVAG (prednisone, vinblastine, doxorubicin, gemcitabine) in elderly patients with early unfavorable or advanced stage Hodgkin lymphoma2011 | 3. lékařská fakulta
- Phase 2 study of parsaclisib (INCB050465), a highly selective, next-generation PI3Kδ inhibitor, in relapsed or refractory diffuse large B-cell lymphoma (CITADEL-202)2021 | Lékařská fakulta v Hradci Králové
- Lenalidomide versus investigator's choice in relapsed or refractory mantle cell lymphoma (MCL-002; SPRINT): a phase 2, randomised, multicentre trial2016 | 1. lékařská fakulta, Lékařská fakulta v Hradci Králové
- Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study2018 | 2. lékařská fakulta
- Efficacy of a novel oral single-agent fumarate, BG00012, in patients with relapsing-remiting multiple sclerosis: results of a phase 2 studyPublikace bez příslušnosti k fakultě
- Vincristine Sulfate Liposomes Injection (Marqibo) in Heavily Pretreated Patients With Refractory Aggressive Non-Hodgkin Lymphoma Report of the Pivotal Phase 2 Study2009 | 3. lékařská fakulta
- Nivolumab for classical Hodgkin's lymphoma after failure of both autologous stem-cell transplantation and brentuximab vedotin: a multicentre, multicohort, single-arm phase 2 trial2016 | 1. lékařská fakulta
- Adjuvant recMAGE-A3 Immunotherapy After Cystectomy for Muscle-invasive Bladder Cancer: Lessons Learned from the Phase 2 MAGNOLIA Clinical Trial2019 | 1. lékařská fakulta, 3. lékařská fakulta, 2. lékařská fakulta
- Sebelipase alfa for lysosomal acid lipase deficiency: 5-year treatment experience from a phase 2 open-label extension study2020 | 1. lékařská fakulta